IDXX vs. SOLV: IDEXX Laboratories vs. Solventum Stock Comparison
How do IDEXX Laboratories (IDXX) and Solventum (SOLV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
IDEXX Laboratories (IDXX) and Solventum (SOLV) both belong to the Health Care Equipment & Supplies industry, though IDXX is classified under Health Care Equipment while SOLV falls under Health Care Supplies.
IDEXX Laboratories (IDXX) carries decades of public-market history since June 21, 1991, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the IDXX side.
| Profile Item | IDXX | SOLV |
|---|---|---|
| Name | IDEXX Laboratories, Inc. | Solventum Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Supplies |
| Market Capitalization | 53.26 billion USD | 15.36 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | June 21, 1991 | March 26, 2024 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | IDXX | SOLV |
|---|---|---|
| Total Return (1Y) | -1.84% | 25.89% |
| Total Return (3Y, Annualized) | 18.42% | -- |
| Total Return (5Y, Annualized) | 2.02% | -- |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
IDEXX Laboratories (IDXX) has an aggressive beta of 1.44, indicating higher sensitivity to broad-market moves, while Solventum (SOLV) is defensive at 0.62 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.
| Metric | IDXX | SOLV |
|---|---|---|
| Volatility (1Y, Annualized) | 37.02% | 30.06% |
| Beta (5Y) | 1.44 | 0.62 |
| Max Drawdown (5Y) | -50.91% | -39.98% |
| Avg. Volume (3M) | 564.80K | 1.05M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | IDXX | SOLV |
|---|---|---|
| Sharpe Ratio (1Y) | -0.17 | 0.72 |
| Sortino Ratio (1Y) | -0.28 | 1.08 |
Profitability
ROE (TTM)
IDEXX Laboratories (IDXX) at 68.93% clears its industry range for ROE, a sharper capital-efficiency signal than Solventum (SOLV) at 3.19%, which is closer to a typical peer reading.
IDXX
Health Care Equipment & Services industry group
68.93%
- IDXX
- 68.93%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
SOLV
Health Care Equipment & Services industry group
3.19%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- SOLV
- 3.19%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
IDEXX Laboratories (IDXX) at 25.36% retains a top-quartile share of revenue as profit, ahead of Solventum (SOLV) at 1.91%, which keeps about the industry-typical share.
IDXX
Health Care Equipment & Services industry group
25.36%
- Max
- 29.35%
- IDXX
- 25.36%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
SOLV
Health Care Equipment & Services industry group
1.91%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- SOLV
- 1.91%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
IDEXX Laboratories (IDXX) at 33.14% operates in the top operating margin quartile, ahead of Solventum (SOLV) at 6.82%, which runs around its industry’s norm.
IDXX
Health Care Equipment & Services industry group
33.14%
- Max
- 35.43%
- IDXX
- 33.14%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
SOLV
Health Care Equipment & Services industry group
6.82%
- Max
- 35.43%
- Q3
- 14.14%
- SOLV
- 6.82%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | IDXX | SOLV |
|---|---|---|
| ROE (TTM) | 68.93% | 3.19% |
| ROA (TTM) | 26.70% | 2.29% |
| Net Margin (TTM) | 25.36% | 1.91% |
| Operating Margin (TTM) | 33.14% | 6.82% |
| Gross Margin (TTM) | 62.72% | 55.13% |
Growth
Revenue Growth
IDEXX Laboratories (IDXX) at 10.42% is around its peer norm for revenue growth, while Solventum (SOLV) at 0.86% drops into the bottom quartile, signaling weaker demand or pricing momentum.
EPS Growth
Solventum (SOLV) at 221.74% clears its industry range for EPS growth, a much stronger earnings trajectory than IDEXX Laboratories (IDXX) at 22.59%, which is closer to a typical peer reading.
Growth Metrics
| Metric | IDXX | SOLV |
|---|---|---|
| Revenue Growth (YoY) | 10.42% | 0.86% |
| Revenue Growth (3Y CAGR) | 8.52% | 0.79% |
| EPS Growth (YoY) | 22.59% | 221.74% |
| EPS Growth (3Y CAGR) | 17.66% | 4.51% |
Financial Strength
Current Ratio (MRQ)
Both IDEXX Laboratories (IDXX) at 1.19 and Solventum (SOLV) at 1.03 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
IDXX
Health Care Equipment & Services industry group
1.19
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- IDXX
- 1.19
- Min
- 0.30
SOLV
Health Care Equipment & Services industry group
1.03
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- SOLV
- 1.03
- Min
- 0.30
Debt / Equity (MRQ)
IDEXX Laboratories (IDXX) at 0.52 carries an industry-typical debt-to-equity mix, while Solventum (SOLV) at 1.10 uses more debt funding than most peers.
IDXX
Health Care Equipment & Services industry group
0.52
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- IDXX
- 0.52
- Q1
- 0.16
- Min
- 0.00
SOLV
Health Care Equipment & Services industry group
1.10
- Max
- 1.88
- SOLV
- 1.10
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | IDXX | SOLV |
|---|---|---|
| Current Ratio (MRQ) | 1.19 | 1.03 |
| Debt / Equity (MRQ) | 0.52 | 1.10 |
| Net Debt / EBITDA | 0.46 | 4.66 |
Dividends
Dividend Yield (TTM)
Neither IDEXX Laboratories (IDXX) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
IDXX
Health Care Equipment & Services industry group
0.00%
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither IDEXX Laboratories (IDXX) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
IDXX
Health Care Equipment & Services industry group
0.00%
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | IDXX | SOLV |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
IDEXX Laboratories (IDXX) at 45.56 is near its industry’s usual P/E ratio, while Solventum (SOLV) at 101.55 sits above its peer range — an unusually expensive price for SOLV’s trailing earnings.
IDXX
Health Care Equipment & Services industry group
45.56
- Max
- 80.41
- Q3
- 47.62
- IDXX
- 45.56
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
SOLV
Health Care Equipment & Services industry group
101.55
- SOLV
- 101.55
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Solventum (SOLV) at 1.88 prices around its industry’s typical P/S ratio, while IDEXX Laboratories (IDXX) at 11.42 clears its benchmark range — IDXX looks notably rich on sales.
IDXX
Health Care Equipment & Services industry group
11.42
- IDXX
- 11.42
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
SOLV
Health Care Equipment & Services industry group
1.88
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- SOLV
- 1.88
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Solventum (SOLV) at 3.20 sits near its industry’s typical P/B ratio, while IDEXX Laboratories (IDXX) at 28.50 prices above its benchmark range — IDXX looks rich relative to book.
IDXX
Health Care Equipment & Services industry group
28.50
- IDXX
- 28.50
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
SOLV
Health Care Equipment & Services industry group
3.20
- Max
- 11.68
- Q3
- 6.12
- SOLV
- 3.20
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | IDXX | SOLV |
|---|---|---|
| P/E Ratio (TTM) | 45.56 | 101.55 |
| P/S Ratio (TTM) | 11.42 | 1.88 |
| P/B Ratio (MRQ) | 28.50 | 3.20 |
| Free Cash Flow Yield (TTM) | 2.00% | 1.31% |